These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20217853)

  • 1. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.
    Leckman JF; Denys D; Simpson HB; Mataix-Cols D; Hollander E; Saxena S; Miguel EC; Rauch SL; Goodman WK; Phillips KA; Stein DJ
    Depress Anxiety; 2010 Jun; 27(6):507-27. PubMed ID: 20217853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers.
    Simpson HB; Reddy YC
    Braz J Psychiatry; 2014; 36 Suppl 1(Suppl 1):3-13. PubMed ID: 25388607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoarding disorder: a new diagnosis for DSM-V?
    Mataix-Cols D; Frost RO; Pertusa A; Clark LA; Saxena S; Leckman JF; Stein DJ; Matsunaga H; Wilhelm S
    Depress Anxiety; 2010 Jun; 27(6):556-72. PubMed ID: 20336805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DSM-5: OCD and related disorders].
    Toro-Martínez E
    Vertex; 2014; 25(113):63-7. PubMed ID: 24887372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder: diagnostic and treatment issues.
    Stein DJ; Denys D; Gloster AT; Hollander E; Leckman JF; Rauch SL; Phillips KA
    Psychiatr Clin North Am; 2009 Sep; 32(3):665-85. PubMed ID: 19716996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of symptom and subtype categories in obsessive-compulsive disorder.
    Besiroglu L; Uguz F; Ozbebit O; Guler O; Cilli AS; Askin R
    Depress Anxiety; 2007; 24(7):461-6. PubMed ID: 17131352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in patients with obsessive-compulsive disorder with good versus poor insight.
    Aigner M; Zitterl W; Prayer D; Demal U; Bach M; Prayer L; Stompe T; Lenz G
    Psychiatry Res; 2005 Nov; 140(2):173-9. PubMed ID: 16256314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.
    Hirschtritt ME; Bloch MH; Mathews CA
    JAMA; 2017 Apr; 317(13):1358-1367. PubMed ID: 28384832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should OCD be classified as an anxiety disorder in DSM-V?
    Stein DJ; Fineberg NA; Bienvenu OJ; Denys D; Lochner C; Nestadt G; Leckman JF; Rauch SL; Phillips KA
    Depress Anxiety; 2010 Jun; 27(6):495-506. PubMed ID: 20533366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preschool children with obsessive-compulsive disorder and fluoxetine treatment.
    Ercan ES; Kandulu R; Akyol Ardic U
    Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):169-72. PubMed ID: 22271063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia.
    Poyurovsky M; Kriss V; Weisman G; Faragian S; Kurs R; Schneidman M; Fuchs C; Weizman A; Weizman R
    J Clin Psychiatry; 2003 Nov; 64(11):1300-7. PubMed ID: 14658943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
    Besiroglu L; Çetinkaya N; Selvi Y; Atli A
    Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive disorders.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2013 Feb; 22 Suppl 1():S23-8. PubMed ID: 23208425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders.
    Say Öcal D; Özdel K; Şafak Y; Kekilli Karnaz Y; Kısa C
    PLoS One; 2019; 14(7):e0218955. PubMed ID: 31276509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders in patients with obsessive-compulsive disorder.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):30-7. PubMed ID: 15679537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.